ACTIVE

GESTIPHARMA

Financial year 2025 · Closed on 31/12/2025

Net result77,5 k €+291,1 %over 1 year

Gross margin230,2 k €+58,7 %over 1 year

Equity815,7 k €+10,5 %over 1 year

Identity

Source · BCE/KBO

GESTIPHARMA is a Public limited company incorporated in 1983. Its main activity is: Management consultancy activities. Its registered office is in Mons.

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0425.530.684
Incorporation: 31/12/1983
Legal form: Public limited company
Registered office: Rue de Montreuil sous Bois(H.) 15
7022 Mons · WallonieSee on map
Contributed capital: 1 483 978,00 €
Latest accounts: 31/12/2025

Activities (NACE)

70200Management consultancy activities· main 70220Business and other management consultancy activities

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 20 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	230,2 k €	+58.7%	145 k €	-4.3%	151,4 k €	+206%	49,6 k €	-48.3%	95,9 k €
EBITDA	154,2 k €	+196%	52,1 k €	-43.6%	92,3 k €	+2961%	-3,2 k €	-107%	45,7 k €
Operating result	76,7 k €	+287%	-40,9 k €	-3292%	1,3 k €	+101%	-93,8 k €	-110%	-44,8 k €
Net result	77,5 k €	+291%	-40,6 k €	-2965%	1,4 k €	+102%	-93,9 k €	-109%	-44,8 k €
Balance sheet
Equity	815,7 k €	+10.5%	738,1 k €	-5.2%	778,7 k €	+0.2%	777,3 k €	-10.8%	871,2 k €
Total assets	859,4 k €	+11.9%	768 k €	-5.3%	810,7 k €	+3.0%	786,8 k €	-10.6%	880,5 k €
Cash	409,1 k €	+67.6%	244,1 k €	+61.1%	151,5 k €	+51.2%	100,2 k €	-3.9%	104,3 k €
Debts	43,8 k €	+46.6%	29,9 k €	-6.7%	32 k €	+235%	9,6 k €	+2.7%	9,3 k €
Other
Workforce	–		–		–		–		–

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 3 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
FINPHARMA SARepresented by PHILIPPE BOULANGER	Director25/11/2022 → 24/11/2028
Pierre-Pascal HECQ	Managing director12/02/2007 → 24/11/2028

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
ASSCOT0447.778.625	Director07/06/2019 → 2022 accounts
UNIVERSAL PHARMA0447.382.113	Director07/06/2019 → 2022 accounts

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Micro model	Micro model	Micro model	Micro model	Micro model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	30/06/2026	14/07/2025	06/08/2024	23/08/2023	16/08/2022	09/08/2021
General meeting	01/06/2026	02/06/2025	03/06/2024	02/06/2023	03/06/2022	04/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2025	01/06/2026	30/06/2026	French	PDF
Micro model	31/12/2024	02/06/2025	14/07/2025	French	PDF
Micro model	31/12/2023	03/06/2024	06/08/2024	French	PDF
Micro model	31/12/2022	02/06/2023	23/08/2023	French	PDF
Micro model	31/12/2021	03/06/2022	16/08/2022	French	PDF
Abridged model	31/12/2020	04/06/2021	09/08/2021	French	PDF
Abridged model	31/12/2019	05/06/2020	25/08/2020	French	PDF
Abridged model	31/12/2018	07/06/2019	08/08/2019	French	PDF
Abridged model	31/12/2017	01/06/2018	20/07/2018	French	PDF
Abridged model	31/12/2016	02/06/2017	03/07/2017	French	PDF
Abridged model	31/12/2015	03/06/2016	19/07/2016	French	PDF
Abridged model	31/12/2014	05/06/2015	14/08/2015	French	PDF
Abridged model	31/12/2013	06/06/2014	17/07/2014	French	PDF
Abridged model	31/12/2012	07/06/2013	25/06/2013	French	PDF
Abridged model	31/12/2011	01/06/2012	19/06/2012	French	PDF
Abridged model	31/12/2010	03/06/2011	12/07/2011	French	PDF
Abridged model	31/12/2009	04/06/2010	29/06/2010	French	PDF
Abridged model	31/12/2008	05/06/2009	23/07/2009	French	PDF
Abridged model	31/12/2007	06/06/2008	23/07/2008	French	PDF
Abridged model	31/12/2006	07/06/2007	20/07/2007	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 3 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
FINPHARMA SARepresented by PHILIPPE BOULANGER	Director25/11/2022 → 24/11/2028
Pierre-Pascal HECQ	Managing director12/02/2007 → 24/11/2028

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
ASSCOT0447.778.625	Director07/06/2019 → 2022 accounts
UNIVERSAL PHARMA0447.382.113	Director07/06/2019 → 2022 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates25/11/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates11/01/2023
DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates12/07/2019
DEMISSIONS, NOMINATIONS
PDF
Capital / shares18/07/2016
CAPITAL, ACTIONS
PDF
Other29/10/2013
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates10/07/2013
Renouvellement des mandats d'administrateurs et de i
PDF
Capital / shares14/02/2012
CAPITAL, ACTIONS
PDF
Registered office20/04/2009
SIEGE SOCIAL
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings20 filings

Mandates

FINPHARMA SA

Pierre-Pascal HECQ

UNIVERSAL PHARMA

ASSCOT

PIERRE PASCAL HECQ

1983198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028

GESTIPHARMALUXIMMO

Rue de Montreuil sous Bois(H.) 15, 7022 Hyon

Director

Managing director

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Rue de Montreuil sous Bois(H.) 15, 7022 HyonCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00242806

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
GESTIPHARMACurrent	accounts 2015 → 2025	Accounts 2025 · 2026-00242806
LUXIMMO	accounts 2006 → 2014	Accounts 2014 · 2015-42500203

Events

2025
Annual accounts 202577,5 k €↑
2024
Annual accounts 2024-40,6 k €↓
2023
Annual accounts 20231,4 k €↑
2022
Annual accounts 2022-93,9 k €↓
2021
Annual accounts 2021-44,8 k €↑
2020
Annual accounts 2020-63,3 k €↓
2019
Annual accounts 2019-26,5 k €↓
2018
Annual accounts 2018145,1 k €↑
2017
Annual accounts 201775,2 k €↑
2016
Annual accounts 20164,2 k €↑
2015
Annual accounts 2015-39,8 k €↓
2015
Name changeGESTIPHARMA
2014
Annual accounts 2014-34,8 k €↑
2013
Annual accounts 2013-54,7 k €↑
2012
Annual accounts 2012-120,6 k €↓
2011
Annual accounts 2011-79,3 k €↓
2010
Annual accounts 2010-65,5 k €↓
2009
Annual accounts 2009-47,5 k €↓
2008
Annual accounts 200842,9 k €↑
2007
Annual accounts 2007-26 k €↓
2006
Annual accounts 2006-19,2 k €
31/12/1983
IncorporationPublic limited company

GESTIPHARMA

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events